Categories AlphaGraphs, Earnings, Health Care
A graphical representation of Abbott Laboratories (ABT) Q1 2020 earnings results
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today.
The company reported a 16% drop in earnings for the first quarter of 2020 due to tax expense despite a 2.5% increase in the top-line. Abbott is suspending its previously announced annual guidance for 2020 due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic.
Abbott launched three critical new tests for COVID-19, two molecular tests and one serology blood test for the detection of the antibody. While molecular testing detects whether someone has the virus, antibody tests determine if someone was previously infected.
Past Performance
Most Popular
KBH Earnings: KB Home Q1 profit drops on lower sales, misses estimates
Homebuilder KB Home (NYSE: KBH) on Monday announced financial results for the first quarter of 2025, reporting lower revenues and profit. The bottom line fell short of expectations. First-quarter net
Can Nike (NKE) achieve sustainable growth under new leadership?
Nike, Inc. (NYSE: NKE) is banking on innovations in its product portfolio and improvements in the operating environment to regain strength, while it continues to grapple with multiple headwinds affecting
Here’s how Lennar (LEN) is navigating a challenging macroeconomic environment
Shares of Lennar Corporation (NYSE: LEN) gained over 1% on Monday. The stock has dropped 11% over the past three months. The homebuilder grew its revenues in the first quarter
